1. Home
  2. ACU vs VRCA Comparison

ACU vs VRCA Comparison

Compare ACU & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$48.94

Market Cap

160.6M

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.84

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
VRCA
Founded
1867
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.6M
137.3M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
ACU
VRCA
Price
$48.94
$6.84
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$50.00
$17.00
AVG Volume (30 Days)
11.0K
32.2K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
1.56%
N/A
EPS Growth
1.63
N/A
EPS
0.24
N/A
Revenue
$196,541,816.00
$35,577,000.00
Revenue This Year
$5.67
N/A
Revenue Next Year
$5.25
$94.44
P/E Ratio
$198.17
N/A
Revenue Growth
1.05
370.22
52 Week Low
$35.50
$0.53
52 Week High
$47.56
$9.82

Technical Indicators

Market Signals
Indicator
ACU
VRCA
Relative Strength Index (RSI) 74.41 61.70
Support Level $40.57 $5.32
Resistance Level N/A $8.19
Average True Range (ATR) 1.58 0.53
MACD 0.40 0.09
Stochastic Oscillator 86.58 82.95

Price Performance

Historical Comparison
ACU
VRCA

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: